SEO URLwww.firestrike.ai/deals/metsera-pfizer-acquisition-2026
acquisitionAnnounced · Jan 12, 2026PharmaceuticalsSource · RumorsArticle · Factual
Pfizer acquires Metsera
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$7.3B
Target
Metsera
NASDAQ: MTSR · New York City, New York
Acquirer
Pfizer
Full Acquisition
Status
Announced
Pfizer agreed to acquire Metsera. Reported deal value: $7.3B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: New York City, New York, United States.
This page summarizes publicly available information about the transaction as of 2026-01-12. Figures and status may change as filings and press coverage update.
Acquisition Reignites Portfolio The purchase of Metsera added several candidates to Pfizer portfolio including MET-097i, a monthly injectable GLP-1 drug
Deal timeline
Announced
Jan 12, 2026 · newsable.asianetnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $7.3B. Figures and status may change as sources update.
Sources: newsable.asianetnews.com · Primary article · FireStrike proprietary index